Announcement of New CEO Appointment
Read more
Mentice has received a €1,062,750 EUR order for simulation solutions from a top 20 global MedTech company
Read more

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on August 13 at 9:30 CET

Thursday, August 6, 2020

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

To register for the presentation of the interim report for the period April  – June  2020, which will be held on August 13 at 9.30 CET, visit www.mentice.com/financial-reports-presentations

The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

For further information, please contact:
Göran Malmberg, CEO, Mentice
Email: 
goran.malmberg@mentice.com

Tel US: +1 (312) 860 5610

Tel Sweden: +46 (0) 703 09 22 22

Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post info@fnca.se

>20 years of innovation in medical simulation | more information at www.mentice.com
Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions.

Ny VD utsedd för Mentice AB
Läs mer
Mentice får en order på simuleringslösningar värd €1,062,750 EUR från ett topp 20 globalt medtech bolag
Läs Mer

Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on August 13 at 9:30 CET

Thursday, August 6, 2020

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.

To register for the presentation of the interim report for the period April  – June  2020, which will be held on August 13 at 9.30 CET, visit www.mentice.com/financial-reports-presentations

The presentation will be held in English. Participants are advised to register at least a few minutes in advance.

For further information, please contact:
Göran Malmberg, CEO, Mentice
Email: 
goran.malmberg@mentice.com

Tel US: +1 (312) 860 5610

Tel Sweden: +46 (0) 703 09 22 22

Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post info@fnca.se

>20 years of innovation in medical simulation | more information at www.mentice.com
Mentice is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular and peripheral interventions are just some of the clinical areas covered by our solutions.